Fundraising Fox

HealthQuest Capital β€” Full Portfolio

22 tracked investments Β· listed companies and verified rows first

Alcrestaalcresta.cominβœ“ verified

Alcresta Therapeutics develops enzyme-based therapeutic products to address nutritional care for enterally fed patients living with rare diseases.

BiotechHealthtechMedical DevicesMassachusetts, US

Daniel Orlando(Chief Executive Officer)Tasos Konidaris(Executive Officer)Martin Paz(Executive Officer)Robert Gallotto(Executive Officer)Daniel Tasse(Executive Officer, Director)William Scheinler(Executive Officer)

Co-investorsBessemer Venture PartnersFrazier Life SciencesThird Rock Ventures

Clearsenseclearsense.cominβœ“ verified

Clearsense operates the 1Clearsense Platform, a healthcare data lakehouse that unifies and manages disparate data for health systems and presents it in simplified, actionable views.

AI & Machine LearningData & InfrastructureDigital HealthHealthtechSaaSJacksonville, US

Ken Misch(Chief Financial Officer and Chief Operating Officer)Jason Rose(Chief Executive Officer)Matt Henderson(Chief Compliance Officer and General Counsel)Jonathan Cook(Chief Technology Officer)Wirick Glenn(Chief Commercial Officer)Eugene Scheurer(Executive Officer, Director)

Co-investorsHealth Catalyst CapitalKairos Venture Investments, Llc

Eyconiseyconis.cominβœ“ verified

Eyconis is a clinical-stage biotechnology company developing long-acting ophthalmic therapies for serious eye diseases such as wet age-related macular degeneration and diabetic macular edema using the TransCon technology platform.

BiotechDigital HealthMedical DevicesRedwood City, US

Emmett Cunningham(Executive Officer, Director)Mark Bachleda(Executive Officer, Director)inRobert Vitti(Executive Officer)Oliver Stauch(Executive Officer)inOliver Boris Stauch(Executive Officer)Conrad Wang(Director)

Co-investorsFrazier Life SciencesvenBio PartnersvenBio Global Strategic

Somatussomatus.cominβœ“ verified

Somatus provides value-based, integrated kidney care and a congestive heart failure management solution for patients, providers, and health plan partners.

Digital HealthHealthtechMclean, US

Ikenna Okezie(Executive Officer, Director)Alexander Houlday(Executive Officer)Stacey Queen-Pyndell(Executive Officer)

BoardAnna Haghgooie(Director)Anthony Welters(Director)

Co-investorsFlare Capital PartnersOptum VenturesBlue Venture FundsDefy PartnersLongitude CapitalRA Capital+4 more

AnswersNowgetanswersnow.comin𝕏Jan 2026 Β· $40M

AnswersNow provides virtual ABA therapy and parent training services for children with autism and their families.

Digital HealthHealthtechRichmond, US

AdamJeff Beck(Executive Officer, Promoter)Jeff Beck, LCSW(Founder)in

Co-investorsAmerican Family Insurance Institute for Corporate and Social ImpactK Street CapitalKapor CapitalLeft Lane CapitalLighthouse Network Ventures LlcOwl Ventures+1 more

Avedroavedro.comin𝕏acquired by Glaukos

BiotechHealthtechMedical DevicesWaltham, US

David F. Muller(Executive Officer, Director)Brian J. Roberts(Executive Officer)Rhonda J. Bracey(Executive Officer)

BoardJason Hong(Director)Jeff Dykan(Director)inAnthony Natale(Director)in

Co-investorsAPERTURE Venture PartnersLAVLilly Asia VenturesSCP Vitalife PartnersThird Point VenturesOrbiMed

Aviziaavizia.cominJan 2015Acquired

Avizia provides a digital care platform integrating technology, services, and devices to support care delivery across in-person, virtual, and automated settings for providers, payers, and patients.

Cloud ComputingDigital HealthEnterprise SoftwareHealthtechBoston, US

Michael Baird(Executive Officer, Director)Ido SchoenbergRoy SchoenbergPhyllis GotlibSteven Luke Leininger(Executive Officer, Director)Corey Costley(Executive Officer)

Co-investorsMartin VenturesNextGen Venture PartnersBlue Delta CapitalLavrock Ventures

Bardybardydx.cominAcquired

BardyDx develops the Carnation Ambulatory Monitor (CAM), a lightweight cardiac patch monitor designed for extended-wear ambulatory ECG monitoring that emphasizes P-wave signal clarity.

Digital HealthHealthtechMedical DevicesSeattle, US

Gust H. Bardy(Executive Officer, Director, Promoter)Mark Querry(Executive Officer)Kevin Nelson, III(Executive Officer)Rik Vandevenne(Director)Alan Levy(Director)Mark Handfelt(Executive Officer, Promoter)

Co-investorsAPERTURE Venture PartnersAphelion CapitalAscension VenturesLumira VenturesRC CapitalRex Health Ventures+1 more

BioIQbioiq.comin𝕏acquired by LetsGetChecked

Digital HealthHealthtechMedical DevicesSanta Barbara, US

Justin Bellante(Executive Officer, Director, Promoter)Brent Peus(Executive Officer)

BoardBrandon Cady(Director)Jeff Closs(Director)Patrick Cua(Director)Kathleen Shanahan(Director)

Co-investorsArboretum Ventures

Connie Healthconniehealth.cominJun 2026 Β· $40M

Connie Health helps older Americans choose and navigate Medicare plans by combining technology with local licensed agents, providing unbiased plan recommendations and an ongoing local care team at no cost to the user.

Digital HealthHealthtechInsurTech

Oded Eran(Co-founder)inDavid Luna(Co-founder)inMichael Scopa(Co-founder)in

Co-investorsAbstract VenturesaMoonArkitekt Venturesat.inc/J-VenturesJSL Health Capital+2 more

Dianagetdiana.comin𝕏Sep 2025 Β· $55M

Diana is a platform for managing flexible work and HR operations.

AI & Machine LearningConsumerDigital HealthEnterprise SoftwareFuture of WorkHR TechSaaSSan Francisco, US

Upeka Bee(Founder)inDilan(Co-founder)inGautamin

Co-investorsY Combinator.406 VenturesAlleyCorpGeneral CatalystLRVHealthNorwest Venture Partners+1 more

Everly Healtheverlywell.comin𝕏

Everlywell offers at-home lab testing kits and virtual healthcare services across multiple wellness categories including daily health screening, digestive analysis, sexual health testing, and hormone monitoring.

Digital HealthHealthtechWellness & Fitness

Julia Cheek(Founder & CEO)

Co-investorsAnsa CapitalHalogen Ventures Management Company LlcNext Coast VenturesNextGen Venture PartnersPortfoliaThe Chernin Group (TCG Crypto)+3 more

HistoSonicshistosonics.comin𝕏

HistoSonics develops histotripsy technology, a non-invasive method that uses focused sound energy to destroy targeted tissue, offered as a medical device for physicians and their patients.

BiotechHardwareHealthtechMedical DevicesAnn Arbor, GB

Thomas Davison(Executive Officer, Director)M. Christine Gibbons(Executive Officer, Director)Wen Chen(Director)Tom Tefft(Director)Michael Blue(Executive Officer, Director)Fred Lee(Director)

Co-investorsAlpha Wave GlobalAmzak HealthEarly Stage Partners, LPLumira VenturesMichigan Capital NetworkBezos Expeditions+2 more

Magnolia Medical Technologiesmagnolia-medical.comin

Magnolia Medical develops diagnostic devices to reduce blood culture contamination and false-positive sepsis test results for hospitals and healthcare systems.

HardwareHealthtechMedical DevicesSeattle, US

Richard G Patton(Director)Gregory J Bullington(Executive Officer, Director)Richard Patton(Co-founder)

BoardPaul Meister(Director)

Co-investorsEvidity Health CapitalLauder PartnersRhapsody Venture PartnersVivo Capital

Nomad Healthnomadhealth.comin

Nomad Health operates an online marketplace that matches travel nurses and allied health clinicians with temporary healthcare jobs based on their profiles and preferences.

Digital HealthHealthtechMarketplacesNew York, US

Alexander Nazem(Director)inMaxwell Laurans(Director)Alexi Nazem(Co-Founder & Board Member)Justin Lambert(CEO)William Eager(Vice President of Engineering)Alexander Pease(Vice President of Product)

Co-investorsAlleyCorpIcon Ventures.406 VenturesAdams Street PartnersFirst Round CapitalPolaris Partners+1 more

OrganOxorganox.comin

OrganOx develops organ preservation and transplantation technology used by research institutions to keep and treat organs, aimed at supporting transplantation and reducing the future need for transplants.

BiotechHealthtechMedical Devices

Co-investorsAmadeus Capital PartnersBusiness Growth FundIntuitive VenturesLauxera Capital PartnersLongwall Venture Partners LLPOxford University Innovation+1 more

Perspectumperspectum.comin𝕏

Perspectum develops non-invasive medical imaging software that extracts diagnostic information from scans to support precision diagnosis of metabolic diseases, cancer, diabetes, and other chronic conditions.

AI & Machine LearningDigital HealthMedical Devices

Co-investorsBlue Venture Funds

Remedy Medsremedymeds.com

Remedy Meds offers personalized medical weight loss treatment using compounded GLP-1 medications (semaglutide and tirzepatide) paired with clinician-led care and support delivered directly to patients.

Digital HealthHealthtech

Co-investors137 VenturesAlpha PartnersDynamism CapitalMaveron

Spiroxspiroxmed.comMar 2016

Menlo Park, US

Duke Rohlen(Chief Executive Officer)

BoardCamille Samuels(Director)Anthony Natale(Director)inReed Gaither(Director)Aftab Kherani(Director)Ron Kuppersmith(Director)

Co-investorsAisling CapitalAPERTURE Venture PartnersCorrelation VenturesVenrockVenrock AssociatesWestern Technology Investment

Thirty Madisonthirtymadison.com

Astoria, US

Demetrius Michael Karagas(Executive Officer, Director)Steven Craig Gutentag(Executive Officer, Director)Steven Gutentag(Founder)in

BoardRebecca Kaden(Director)in

Co-investorsComcast VenturesConnetic VenturesCVS Health VenturesEvolution VC PartnersForeground CapitalGreycroft+11 more

Tricetrice.coin

Trice provides an embedded payment API that connects to RTP and FedNow rails for real-time, irrevocable money-in and money-out transfers.

Developer ToolsFintechSaaS

Co-investorsDiagramFINTOP CapitalBioStar Ventures

Venus Conceptvenusconcept.comin𝕏

Venus develops non-invasive, energy-based medical aesthetic devices for body, face, skin, and hair treatments, integrating robotics, AI, and IoT technologies.

BiotechHardwareHealthtechMedical DevicesToronto, US

Domenic Serafino(Executive Officer, Director)Kirk Gunhus(Executive Officer)Ross Portaro(Executive Officer)Anna Georgiadis(Executive Officer)Melissa Kang(Executive Officer)Michael Mandarello(Executive Officer)

Co-investorsAPERTURE Venture PartnersEssex Woodlands Healthcare PartnersLongitude CapitalClarus

Rows marked β€œSEC filing” are inferred from directors named on the company's SEC Form D β€” public regulatory data, not a portfolio list published by the firm.